Fortwin 1ml Injection is a pain-relieving medicine. It is used to manage persistent, moderate to severe chronic pain that requires continuous, around-the-clock treatment for an extended period of time.
“Dabur Khadiradi Gutika” has been added to your cart. View cart
-10%

Flurilept Tablet
₹153.00 Original price was: ₹153.00.₹138.00Current price is: ₹138.00.

Chericof Junior Syrup
₹90.00 Original price was: ₹90.00.₹81.00Current price is: ₹81.00.
Fortwin 1ml Injection 1
₹5.58 Original price was: ₹5.58.₹5.00Current price is: ₹5.00.
Fortwin 1ml Injection helps to relieve moderate to severe pain in conditions that affect joints and muscles. It works by blocking chemical messengers in the brain that tell us we have pain. It can help relieve pain in conditions like rheumatoid arthritis and osteoarthritis.
Categories: Ortho/Joint Recovery, Pain Relief
Description
Reviews (0)
Be the first to review “Fortwin 1ml Injection 1” Cancel reply
Related products
Baidyanath Vatrina Tablet
Dabur Ablari
Dabur Gokshuradi Guggulu
Dabur Mahavat Vidhvansan Tablet
Dabur Pilochek Tablet
- Dabur Pilochek Tablet is indicated for the treatment of haemorrhoids, providing relief from symptoms such as pain, itching, and discomfort associated with this condition
- Dabur Pilochek Tablet is indicated for the treatment of bleeding piles, which are haemorrhoids that cause bleeding. It may help in reducing bleeding and promoting healing
- The tablet may help in relieving constipation, which can be a contributing factor to the development or worsening of haemorrhoids. By addressing constipation, it may indirectly support the management of haemorrhoids
Dabur Rheumatil Oil 100ml
- Guggulu and mahanarayan oil has anti-inflammatory action that helps relieve redness and swelling of musculoskeletal tissues and strengthens joint movements
- Nirgundi has analgesic action that reduces pain, swelling, and stiffness of joints
- Rasna, guggulu, and prasarini aids in comfortable joint movements
- Gandhapura oil and capsaicin helps relieve pain
Reviews
There are no reviews yet.